Advertisement

Organisation › Details
Gilead Sciences Inc. (Nasdaq: GILD)
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. *
![]() |
Start | 1987-06-22 established |
Group | Gilead Sciences (Group) | |
![]() |
Industry | biopharmaceutical |
Industry 2 | virostatic agent | |
Street | 333 Lakeside Drive | |
City | 94404 Foster City, CA | |
Address record changed: 2015-04-24 | ||
Basic data | Employees | n. a. |
Currency | USD | |
Annual sales | 4,230,045,000 (revenues, total, consolidated (2007) 2007-12-31) | |
Profit | 1,615,298,000 (2007-12-31) | |
Cash | 2,722,422,000 (2007-12-31) | |
* Document for �About Section�: | ||
Record changed: 2019-11-27 |
Advertisement
![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
More documents for Gilead Sciences (Group)
- [1] Gilead Sciences, Inc.. (7/19/19). "Press Release: Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis". Foster City, CA....
- [2] Hookipa Pharma Inc.. (5/8/19). "Press Release: Hookipa Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead". New York, NY & Vienna....
- [3] Gilead Sciences, Inc.. (4/12/19). "Press Release: Gilead Sciences and Novo Nordisk Announce Intent to Initiate a Clinical Collaboration in NASH". Foster City & Bagsvaerd....
- [4] Hookipa Pharma Inc.. (1/2/19). "Press Release: Hookipa Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead". New York, NY & Vienna....
- [5] Gilead Sciences, Inc.. (12/10/18). "Press Release: Gilead Sciences Names Daniel O’Day Chairman and Chief Executive Officer". Foster City, CA....
- [6] Hookipa Biotech AG. (6/5/18). "Press Release: Hookipa and Gilead Enter into a Collaboration and License Agreement to Develop Immunotherapies Against HIV and Hepatitis B". Vienna & Foster City, CA....
- [7] Cell Medica Ltd.. (8/1/18). "Press Release: Cell Medica Appoints New CEO to Drive CAR and TCR Clinical Development and Commercialisation". London & Houston, TX....
- [8] Gilead Sciences, Inc.. (10/3/17). "Press Release: Gilead Sciences Completes Acquisition of Kite Pharma, Inc.". Foster City, CA....
- [9] Medigene AG. (8/30/17). "Press Release: Medigene Presents Automated Platform for TCR Identification at CAR-TCR Summit". Planegg....
- [10] Kite Pharma, Inc.. (8/28/17). "Press Release: Gilead Sciences to Acquire Kite Pharma for $11.9 Billion. Immediately Positions Gilead as a Leader in Cell Therapy". Foster City, CA & Santa Monica, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top